首页 正文

Successful use of cemiplimab in a high immunologic risk kidney transplant recipient with metastatic squamous cell carcinoma

{{output}}
The widespread use of immunotherapy in the management of cancers has led to improved overall survival and progression free survival. Due to increased risk of allograft rejection, organ transplant recipients are often excluded in clinical trials or offered immu... ...